Rodman & Renshaw analyst Tony Butler initiates coverage on CRISPR Therapeutics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

New Coverage

CRISPR Therapeutics (CRSP) PT Lowered to $60 at RBC CapitalAugust 6, 2024 6:43 AM